Ecstasy and related substances;L'ecstasy et ses 'sosies'

Presse Medicale

Volumn 28, Issue 7, 1999, Pages 358-362

  Galliot Guilley, M ^a   Sueur, C ^b   Lebeau, B ^b   Fompeydie, D ^a   Benezech, A ^b   Bazard, J P ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; BUFLOMEDIL; CANNABIS; CHLOROQUINE; IBUPROFEN; KETAMINE; PHENETHYLAMINE DERIVATIVE; PHENYLTOLOXAMINE CITRATE; PREDNISONE; PREDNISONE ACETATE; PSYCHOTROPIC AGENT; RINUREL; TRIAMINIC; UNCLASSIFIED DRUG; VICKS RUB; AMPHETAMINE DERIVATIVE;

CHEMICAL ANALYSIS; DRUG FORMULATION; DRUG INFORMATION; DRUG MECHANISM; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FRANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; REVIEW; SUBSTANCE ABUSE; ADDICTION; ADOLESCENT; ARTICLE; FEMALE; MALE;

ADOLESCENT; AMPHETAMINES; FEMALE; FRANCE; HUMANS; MALE; PHENETHYLAMINES; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 0033585766     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Shulgin Al, Shulgin Ann, Pihkal: A chemical love story. Transform Press, Berkeley, USA, 1993.
2. Grob CS, Russell EP, Linda C, Thomas E. Psychobiologic effects of 3,4 methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behavioural Brain Research 1996 ; 73:103-7
3. Steele TD, Mac Cann UD, Ricaurte GA. Methylenedioxymethamphetamine (MDMA, Ecstasy): plasmacology and toxicology in animals and humans. Addiction 1994 ; 89:539-51.
4. Ricaurte CA, Fomo LS, Wilson MA et al. MDMA selectively dammages central serotonergic neurons in primate. JAMA 1988 ; 260:51-5.
5. Ricaurte GA, De Lanney LE, Irwin I, Langston JW. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of administration. Brain Research 1988 ; 446:165-8.
6. Sueur C. L'usage d'ecstasy en France. Prévention des risques dans les raves et traitement des complications psychopathologiques. International conference on Ecstasy and psychedelics. The State of the Art, Bologne, 17-18 novembre 1996, Assessorato Politiche Sociali e Familiari, paru dans Interventions 1997 ; 58:3-14.
7. Sueur C. Recherche-Action-Prévention, Nouvelles drogues, nouveaux usages, MDM, Direction Générale de la Santé, septembre 1997.
8. Sueur C, Bastianelli M, Benezech A et al. De la Rave à la Prev expérience de prévention en milieu techno. Dans-Cités 1997 ; 12:8-10.
9. Fromberg E. Harm reduction and XTC, International Conference on Ecstasy and Psychedelics. The State of the Art, Bologne, 17-19 novembre 1996, Assessorato Politiche Sociali e Familian. Interventions 1998 ; 64:26-37.
10. Benezech A. Testing Story, document MDM, février 1998.
11. Recherche sur les usagers d'ecstasy en Gironde. CEID-OFDT, février 1998.